1. Home
  2. ARDX vs CDRE Comparison

ARDX vs CDRE Comparison

Compare ARDX & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.97

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$29.85

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
CDRE
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ARDX
CDRE
Price
$6.97
$29.85
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$15.14
$39.67
AVG Volume (30 Days)
3.8M
357.0K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
1.46%
EPS Growth
N/A
13.33
EPS
N/A
1.02
Revenue
$2,607,000.00
$610,308,000.00
Revenue This Year
$37.75
$23.72
Revenue Next Year
$34.24
$6.89
P/E Ratio
N/A
$30.30
Revenue Growth
N/A
7.53
52 Week Low
$3.54
$27.32
52 Week High
$8.40
$48.76

Technical Indicators

Market Signals
Indicator
ARDX
CDRE
Relative Strength Index (RSI) 62.75 44.54
Support Level $6.83 $29.19
Resistance Level $8.23 $31.48
Average True Range (ATR) 0.36 1.37
MACD 0.11 0.28
Stochastic Oscillator 69.88 55.69

Price Performance

Historical Comparison
ARDX
CDRE

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

Share on Social Networks: